News

A recent report described three cases of infants with thrombocytopenia who were successfully treated with romiplostim.

Families of patients with NICU stays due to severe conditions reported telemedicine appointments improved adaptation after discharge.

Fetal maternal hemorrhage, a potential cause of FNAIT, must treated as soon as possible, a recent case report and literature review found.

A recent study identified a pathway linking necrotizing enterocolitis, a complication of FNAIT, to reduced asthma severity in adulthood.

In a recent case report, early use of heparin safely dissolved a life-threatening bleed and blood clot in the brain of a newborn.

A recent review highlights the potential of targeting the neonatal Fc receptor (FcRn) in several diseases, including FNAIT.

The study showed immune thrombocytopenia caused most maternal near-miss cases, especially when platelet counts dropped below 50×10⁹/L.

A novel mutation, revealed by advanced genetic analysis, caused fetal and neonatal alloimmune thrombocytopenia (FNAIT) in a newborn.

The addition of a sugar molecule (fucosylation) to IgG antibodies could help in determining the severity of alloimmune diseases like FNAIT.

Artificial intelligence is enhancing newborn healthcare by providing an avenue for earlier diagnosis.